Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-02-03 @ 3:49 AM
Study NCT ID:
NCT01664156
Status:
COMPLETED
Last Update Posted:
2014-03-14
First Post:
2012-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and Feet
Sponsor:
The Korean Society of Ginseng
Organization:
Study Overview
Official Title:
Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and Feet : a Randomized, Double-blind, Placebo-controlled Trial
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1. Objectives
1. to verify effect of Korean red ginseng on cold hypersensitivity of hands and feet in women
2. to establish scientific evidence for the use of Korean red ginseng by investigating changes of infrared thermography
2. Hypothesis The hypothesis is that Korean red ginseng will reduce cold hypersensitivity of hands and feet more effectively than placebo after 8 weeks administration of interventions- Korean red ginseng or the placebo.
1. to verify effect of Korean red ginseng on cold hypersensitivity of hands and feet in women
2. to establish scientific evidence for the use of Korean red ginseng by investigating changes of infrared thermography
2. Hypothesis The hypothesis is that Korean red ginseng will reduce cold hypersensitivity of hands and feet more effectively than placebo after 8 weeks administration of interventions- Korean red ginseng or the placebo.
Detailed Description:
Design
* This trial is a randomized, double blind, placebo controlled trial with 80 patients.
* The trial will be implemented at Kyung Hee University Hospital at Gangdong in Seoul, Korea.
* Participants will take Korean red ginseng or placebo for 8 weeks and will be followed up during 4 weeks.
* During the administration period, 6 capsules 2 times a day (1h after breakfast and dinner) of Korean red ginseng or its placebo will be provided.
* This trial is a randomized, double blind, placebo controlled trial with 80 patients.
* The trial will be implemented at Kyung Hee University Hospital at Gangdong in Seoul, Korea.
* Participants will take Korean red ginseng or placebo for 8 weeks and will be followed up during 4 weeks.
* During the administration period, 6 capsules 2 times a day (1h after breakfast and dinner) of Korean red ginseng or its placebo will be provided.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: